Regulatory aspects of stability testing in Europe

Drug Development and Industrial Pharmacy

Volumn 25, Issue 7, 1999, Pages 831-856

  Matthews, Brian R ^a  

^a Alcon Laboratories Ltd UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DESIGN; DRUG DOSAGE FORM; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG STABILITY; DRUG STORAGE; EUROPE; GLOBAL CLIMATE; REVIEW; SHELF LIFE;

DRUG INDUSTRY; DRUG STABILITY; EUROPEAN UNION; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS;

EID: 0033014363     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100102245     Document Type: Review

References (1)

1. Committee for Proprietary Medicinal Products, European Commission, The Rules Governing Medicinal Products in the European Union, Vol. 3, Guidelines: Medicinal Products for Human Use, Part A, Quality and Biotechnology, European Commission, 1998, p. 129.